| Prev Close | 66.94 |
| Open | 67.31 |
| Day Low/High | 67.06 / 68.64 |
| 52 Wk Low/High | 43.96 / 74.70 |
| Volume | 2.39M |
Centene Corporation (CNC)
67.48
0.54
0.81
NYSE
| Exchange | NYSE |
| Shares Outstanding | 579.47B |
| Market Cap | 38.23B |
| P/E Ratio | 22.45 |
| Div & Yield | N.A. (N.A) |
Latest News
Here's a Healthy Investing Opportunity
Centene is a $110 billion in revenue company you've probably never heard of. Here's how to play it.
Still Waiting for Centene to Make an Upside Move
Technical analysis and trading strategy for the healthcare plan provider.
Jim Cramer: Why You Shouldn't Expect the Market to Get Clobbered Again Monday
Let's go over the confluence that allowed us to advance after a brief dip down in the morning.
Centene Stock Looks a Little Vulnerable Right Now
Trade carefully.
Wait for it: Centene Could Break Out to New Highs
Overall the charts of CNC are constructive but I would still want to buy strength.
Small-Caps Roar, Bets Against the Market, Trading Nvidia
Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.
Jim Cramer: One Thing This Market Doesn't Lack Is Confidence
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."
Centene: What's Next for Shares of the Health Plan Provider?
Let's see what the charts look like the day after the State of the Union address.
Jim Cramer: Here's Why the Market Hasn't Stopped Rallying
These are the 10 reasons why we keep going up, despite all the bad news.
Drug Companies Are a Political Football, Trading Amgen: Market Recon
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
Centene Is Finally Showing Some Bullish Divergences
It is early in the game but here's what traders can do.
Jim Cramer: The Soundness of My Methods
A little bit of luck and a lot of homework can go a long way to make Big Money out of Mad Money. It's buying a Biogen, a Centene, or a Bristol-Myers that could do just that for you.
China Trade Optimism, Do Boeing's Numbers Matter? Trading Apple: Market Recon
There is a chance that Presidents Trump and Xi sign something when they meet up at the APEC summit this November in Santiago, Chile.
Centene Shows Improvement After a Long Decline
Downside momentum has been slowing in the healthcare company's shares, which could foreshadow a low or a reversal.
Earnings Volcano Erupts, Locking In on Lam, and Apple-Intel Intel: Market Recon
Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.
Centene Is Transitioning From a Downtrend to a Base Pattern
A rally above the highs of April and May or above $58 will be positive for the provider of healthcare programs.
3 Managed Care Providers Are Finally Looking Promising on the Charts
A look at the charts and indicators of three big names in the sector .
Jim Cramer: With Biden the Democratic Favorite, These Stocks Are Front-Runners
These managed care stocks can withstand China, politics and a slowdown in the economy.
The FANGs Ride Again, Plus Mercury Systems Rising: Market Recon
Netflix led the charge in FANG names. And why MRCY is now a hot stock in the defense sector.
Chart of the Day: UNH's Universal Healthcare Comments Sting Sector
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
Complexity Theory, Operation Un-Twist, Managed Care Stocks: Market Recon
It becomes difficult to own for anything other than a trade, managed care stocks and those that most benefit from Medicare expansion.
Centene Splits 2 For 1 Which Changes the Chart Levels but Not the Trends
With the stock split a fresh look at the split adjusted stock is now in order.
3 Key Bear Market Rules, 5 Bargain Buys and a Monthly Dividend Portfolio
Dow Theory presents tips for surviving a bear market, some top year-end stock bargains and a simple strategy for monthly income.
Sagging Centene Appears Vulnerable to Further Declines
Shares of the healthcare company are showing unhealthy tendencies right now after a federal judge rules Obamacare unconstitutional.
Jim Cramer: The Operative Term for This Tape Is Treacherous
Use it to your advantage or don't use it at all.
Crafting a Trading Strategy for Centene Stock
CNC could wobble with the broader market.
Centene Looks Like It Is Weakening With the Broader Market
Longs should take appropriate action.
